Clinical Trial Update: Fenofibrate for Prevention of DR Worsening [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fenofibrate to prevent worsening of diabetic retinopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetic Retinopathy | Phase 3 | Status: RECRUITING